Enhanced water-solubility of albendazole by hydroxypropyl-β-cyclodextrin complexation

Journal of Inclusion Phenomena and Molecular Recognition in Chemistry

Volumn 25, Issue 1-3, 1996, Pages 149-152

  Bassani, V L ^a   Krieger, D ^a   Duchene, D ^b   Wouessidjewe, D ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIV PARIS SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0010630314     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01041557     Document Type: Article

References (7)

1. Gyurik, R.J., Chow, A.W., Zaber, B., Brunner, E.L., Miller, J.A., Villani, J.A., Petka, L.A., Parish, R.C., Metabolism of albendazole in cattle, sheep, rats, and mice, Drug Met. Disp., 9, 503-508 (1981).
2. Prieto, J.G., Alonso, M.L., Justel, A., Santos, L., Tissue levels of albendazole after in vivo intestinal and gastric absorption in rats, J. Pharm. Biomed. Anal., 6, 1059-1063, (1988).
3. Fourestié, V., Bougnoux, M.E., Ancelle, T., Liance, M., Roudot-Thoraval, F., Naga, H., Pairon-Pennachioni, M., Rauss, A., Lejonc, J.L., Randomized trial of albendazole versus tiabendazole plus flubendazole during an outbreak of human trichinellosis, Parasitol Res., 75, 36-41, (1988).
4. Davis, A., Multicentre clinical trials of bendimidazole carbamate in human echinococcosis, Bull. WHO., 64, 384-388, (1986).
5. Khata, M., Schauer, M., Increasing of the solubility characteristics of albendazole with dimethyl-β-cyclodextrin, Acta Pharm. Hung., 61, 23-31, (1991).
6. Bogan, J.A., Marriner, S.E., Pharmacodynamic and toxicological aspects of albendazole in man and human, in Proc. Int. Congr. Ser R. Soc. Med., 61, 13-21, (1984).
7. th. EAVPT. Congr. Copenhagen, 1991, Pp. 385-386.